ArticleBMC complementary medicine and therapies2024

Biochanin A abrogates osteoclastogenesis in type 2 diabetic osteoporosis via regulating ROS/MAPK signaling pathway based on integrating molecular docking and experimental validation.

Qi He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.